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ABSTRACT 
Purpose: The purpose of this study is to assess risk factors associated with TB co-
infection in HIV/AIDS patients taking antiretroviral therapy (ART).  
Methodology: An observational, analytic, case-control and quantitative study was 
conducted on a randomly selected 367 HIV and AIDS patients of whom 92 of them were 
TB co-infected. Data collection was done by using self-structured questionnaire. 
Result: In this study, educational status, waste disposal system, monthly income, contact 
history with a patient of active tuberculosis or presence of a family member with active 
tuberculosis, drug adherence, knowledge on tuberculosis prevention and history of 
exposure to substance were factors independently associated with the occurrence of active 
tuberculosis among HIV and Aids patients taking ART.   
Conclusion: The findings highlight the need for on-going educational, informational and 
other interventions to address the risk factors of tuberculosis in HIV and Aids patients in 
order to decrease the rate of TB co-infection.   
KEY TERMS:  
Antiretroviral therapy, Cases, Case-control study, Controls, Drug adherence, HIV/AIDS, 
Risk factors, Public health facility, Tuberculosis, TB/HIV co-infection 
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CHAPTER 1 
ORIENTATION TO THE STUDY 
1.1 INTRODUCTION 
 
The global impact of the converging dual epidemics of tuberculosis (TB) and human 
immunodeficiency virus (HIV) are major public health challenges of our time. Tuberculosis 
is the most common opportunistic infection and leading cause of death in HIV-infected 
patients (Swaminathan and Narendran  2008: 527). Tuberculosis and HIV combined are 
responsible for the deaths of over 4 million people annually. TB is one of the most common 
infections that threaten people living with HIV in the developing world. The World Health 
Organization (WHO) reports that from 9.2 million new cases of TB in 2006, 7.7% were HIV 
infected and of the 1.7 million deaths from TB in 2008, almost one third were people 
co‐infected with HIV or AIDS (WHO, 2009: 2). 
 
There were an estimated 1.1 million HIV positive TB patients globally in 2009. Around 80% 
of these patients live in sub Saharan Africa. In 2009, 380,000 people died of HIV 
associated Tuberculosis. It is the most common presenting illness among people living with 
HIV including those who are taking antiretroviral therapy (ART). At least one third of the 
33.3 million people living with HIV worldwide are infected with Tuberculosis. (WHO 2011: 
1-3). 
Infection with Human Immunodeficiency Virus (HIV) is an established risk factor for 
acquiring and developing infection with tuberculosis, and the recent increase in the 
worldwide prevalence of HIV infection has contributed to the rising global incidence of TB 
(Corbett et al 2003:1009-1021; Dye et al 1999: 677-686). Over two-thirds of the 15 million 
cases of dual-HIV/TB infection reported reside in sub-Saharan Africa. However, as HIV 
expands in other parts of the world, such as in South-east Asia, the interaction between 
these two pathogens will continue to expand and compound the health issues related to 
both infections (Kumar 1999:1010-1011). 
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HIV infected patients on antiretroviral therapy (ART) have a Tuberculosis incidence rate of 
5.4 cases/100 patient-years, approximately 10-fold higher than tuberculosis incidence rates 
in HIV negative patients in the same community. Contact with infectious person, lack of 
knowledge on how to prevent Tuberculosis, environmental factors like poor ventilation, 
residence area, gender, and previous history of Tuberculosis are among the risk factors 
associated with the occurrence of Tuberculosis in HIV and Aids patients on ART (Nicholas 
et al 2008:1). 
Ethiopia is one of the sub-Saharan African countries most severely affected by TB and HIV 
and Aids epidemic. The national single HIV and Aids prevalence rate among adults was 
estimated to be 2.4% for the year 2010. The country is one  of the top ten high TB burden 
countries with an incidence rate of 341/100,000 of which 31% of TB patients are HIV 
positive (Federal HIV and Aids Prevention and Control Office, 2010). The distribution of 
TB/HIV co-infection by region shows there is greater prevalence in Oromia region of 
Ethiopia and Nekemte town, where this study was conducted, is one of the largest towns in 
Oromia region located to the west part of the country about 331km away from Addis 
Ababa.( FMOH, Health and Health related Indicators, 2007/8: 33). 
1.2 BACKGROUND INFORMATION 
The effect of HIV on TB is better understood as it is more straightforward than the effect of 
Tuberculosis on HIV disease progression. The immune system uses CD4 cells to defend 
the body against tuberculosis, and a decline in CD4 cells (due to HIV) thus lessens the 
immune system’s ability to prevent the growth and spread of Mycobacterium tuberculosis. 
Additionally, a weakened immune system allows the dissemination of the bacteria to areas 
other than the lungs, which explains the increased likelihood of extra pulmonary TB among 
HIV positive individuals (WHO 2004:36-39). 
TB has a more technical interaction with HIV and is thought to increase HIV replication and 
viral load, thus worsening the course of HIV related immunodeficiency. Much research has 
been done to reveal the mechanisms by which these interactions occur and the general 
consensus is that both promoter enhancement and cytokine activity play key roles in the 
heightened HIV activity seen in the presence of Mycobacterium tuberculosis. 
(Subramanyam et al 2004: 101-106). Research also shows that TB may reactivate latent 
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HIV in monocytes recruited to sites of Mycobacterium Tuberculosis infection via a 
stimulatory transcription factor and that latent HIV reservoirs are established at sites of 
mycobacterium tuberculosis infection (Weiden et al 2000: 2028-2039). There is also 
evidence that TB increases systemic HIV heterogeneity which could have future 
implications for resistance to antiretroviral (ARV) drugs (Collins et al 2001: 233-238). 
TB and HIV co-infected patients have a lower quality of life in all domains as compared to 
HIV infected patients without active TB. In co-infected patients, individuals who had 
depression were 8.8 times more likely to have poor physical health as compared to 
individuals who had no depression (Deribew et al 2009:105). 
1.3 RESEARCH PROBLEM 
  
A comprehensive strategy focusing on major risk factors of TB is essential to achieve the 
‘Stop TB’ partnership targets (Dye et al 2006: 460-462). Risk factors of TB can be 
categorized as distal or proximate. Distal risk factors such as socio-economic status 
contribute to the development of TB indirectly whereas proximate determinants include 
those that increase exposure to the infectious agent such as crowding and that impair the 
host immune system. Assessment of proximate determinants of TB which are amenable to 
interventions such as the host and environmental factors help to target strategies (Lonnroth 
et al 2009: 2240-2246). Several studies on risk factors of TB were conducted in the general 
population but the proximate determinants of active TB among HIV patients are not well 
elucidated in countries with limited resources (Lienhardt et al 2005: 914-923).  
A recent review of tuberculosis in Ethiopia noted that ‘existing information on the 
association between HIV and TB in Ethiopia is limited’. Although hospital-based cross 
sectional studies in Ethiopia have reported that most of tuberculosis patients were co-
infected with HIV (Kassu et al 2007: 116-122), with recent estimates ranging from 46% to 
65%, no analyses have assessed the risk factors of TB in HIV and Aids patients on ART in 
Ethiopia both at a national and regional level.  
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1.4 RESEARCH PURPOSE 
 
The aim of the study was to assess risk factors associated with tuberculosis co-infection 
among HIV and Aids patients taking ART.  
1.5 RESEARCH OBJECTIVES 
 
The objectives of this research were to: 
• Determine the socio demographic risk factors associated with TB co-infection in  
HIV and Aids patients taking antiretroviral therapy in Nekemte Hospital, Western 
Ethiopia. 
• Identify behavioural and economic risk factors associated with TB co-infection in HIV 
and Aids patients taking antiretroviral therapy in Nekemte Hospital, Western 
Ethiopia. 
• Assess knowledge on TB co-infection among HIV/Aids patients taking antiretroviral 
therapy in Nekemte Hospital, Western Ethiopia. 
   1.6 FOUNDATION OF THE STUDY 
  
The theoretical framework of the study is based on the assumption that the possibility of 
individuals infected with HIV and Aids to get infected with tuberculosis is highly dependent 
on their knowledge of TB and HIV co-infection, their socio-economic status, risk behaviours 
such as exposure to substances, the frequency of regular monitoring CD4 level, and their 
level of drug adherence. Prevention of TB co-infection can also decrease morbidity and 
mortality rate among patients on ART, and this in turn would increase their productivity. 
This also indicates that when individuals are aware of the overall aspect of TB co-
morbidity, their health service seeking behaviour will positively change. Therefore, the 
framework shows that it is the responsibility of health care delivery institutions, health 
professionals, government bodies, and different stakeholders to tackle the problem by 
taking different measures such as poverty reduction, equipping the health facilities with 
equipment and supplies, increasing awareness of the community on the problem, and 
formulating appropriate policy.  
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 1.7 SIGNIFICANCE OF THE STUDY 
 
Despite the increasing number of TB/HIV co-infection in Ethiopia, little is known about what 
predisposes patients on antiretroviral therapy (ART) to TB co-infection. Therefore, the 
findings of this study provide information about risk factors to improve areas of health care 
services regarding the prevention and TB/HIV management. The study also serves as a 
baseline for further studies. The study findings also directly or indirectly could benefit the 
policy makers, researcher, participants, and the community in general. 
 1.8 ETHICAL CONSIDERATIONS 
  
Before conducting the study, ethical clearance was obtained from Higher Degrees 
Committee of the Department of Health Studies of the University of South Africa. 
Institutional consent was obtained from Nekemte city health bureau and Nekemte hospital. 
The ethical protection of respondents was maintained throughout this study. 
1.9 RESEARCH METHODOLOGY  
   1.9.1 Research Design 
A case control study design was used to assess the risk factors associated with TB co-
infection in HIV and Aids patients taking antiretroviral therapy (ART) in Nekemte Hospital, 
Western Ethiopia.  
   1.9.2 Research Setting 
The research was conducted in Nekemte town, in the Western part of Ethiopia which has 
six sub cities. According to Nekemte town municipality statistics office, the total population 
of the town in 2008/9 was 90,605. Among these 44,396 are males and 46,209 are females. 
There are five governmental health institutions (One hospital, two health centres, and two 
pharmacies) in the city. 
   1.9.3 Population and Sample 
The research population consisted of all HIV and Aids patients who are both co infected 
and non co infected with Tuberculosis who have access to ART service in public health 
facilities in Nekemte town. 
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 1.10 DEFINITIONS OF KEY CONCEPTS 
 
Acquired immunodeficiency syndrome (AIDS)-is a disease of immune system caused 
by infection with a retro virus HIV. 
Active Tuberculosis-TB that has been confirmed by clinical and positive sputum smear or 
chest x-ray result suggestive of TB   
Antiretroviral therapy(ART) - A name given to treatment regimens recommended by 
leading HIV experts to aggressively suppress viral replication and progress of HIV disease.  
CD4 count- a way of measuring immune-competency by counting the lymphocyte that 
carries the CD4 molecules  
Co-infection -The existence of two or more disease at a time. 
Human immunodeficiency virus (HIV)-is a virus that attacks the CD4 cells or T cells that 
are responsible for the body’s defence system.  
Public health facility- Is a Government owned health service delivery institution serving 
the community at a reasonable cost. 
Risk Factor- A feature of somebody’s habits, socio-economic, environmental, genetic 
makeup or personal history that increases the probability of disease or harm to health. 
Tuberculosis- is an infectious disease that causes small rounded Tubercles to form on 
mucous membranes, especially pulmonary tuberculosis that affects the lungs. 
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1.11 ORGANISATION OF THE DISSERTATION 
The Research has the following Chapters: 
Chapter 1:  Orientation to the study  
Chapter 2: Literature review  
Chapter 3: Research methodology 
Chapter 4: Presentation and discussion of research results 
Chapter 5: Conclusions, limitations and recommendations 
 
1.12 CONCLUSION 
 
This chapter presented an introduction, background of the research problem both globally 
and in Ethiopian context, research purpose, research objectives, foundations of the study, 
significance of the study, ethical considerations, research methodology, and definitions of 
key concepts.   
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CHAPTER 2 
LITERATURE REVIEW 
2.1 INTRODUCTION 
 
This chapter presents the Global situation of TB, TB and HIV, HIV and AIDS, and the 
situation in sub-Saharan Africa and lastly the situation in Ethiopia. Secondary sources such 
as books, policy documents, electronic resources, and journal articles on risk factors on 
TB/HIV co-infection were used in the literature review. 
 
Volmink (2007: 66) states that a literature review is indispensable if one wants to know  
          1) The current state of knowledge about any given subject, 
          2) What still needs to be studied so that the direction of future research can be  
            efficiently determined, and 
          3) How available resources should be optimally allocated and distributed. 
 
The outline of the literature review is: 
• Global HIV and Aids 
• HIV and Aids in sub Saharan Africa 
• HIV and Aids in Ethiopia 
• Global TB infection 
• TB in Africa 
• TB in Ethiopia 
• TB/HIV co-infection 
2.2 GLOBAL HIV and AIDS 
  
Since its detection in 1981, HIV and Aids has become one of the most challenging 
problems of our age. There are 34.2 million people living with HIV, 2.5 million new HIV 
infections and 1.7 million deaths due to AIDS worldwide in 2011. From the total number of 
people living with HIV in 2011, 30.7 million are adults, 16.7 million are women and about 
3.4 million are children below the age of 15. From these 2.2 million Adults and 330,000 
under 15 age group are people newly infected with HIV in 2011. In addition, out of the total 
1.7 million deaths in 2011, 230,000 are children below 15 years of age while the rest are 
adults (UNAIDS/WHO, 2012: 2-3).  
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At the end of 2010, an estimated 34 million people were living with HIV worldwide, a 17% 
increase from 2001. This reflects the continued large number of new HIV infections and a 
significant expansion of access to antiretroviral therapy, which has helped reduce AIDS-
related deaths, especially in more recent years. The number of people dying of AIDS-
related causes fell to 1.8 million in 2010, down from a peak of 2.2 million in the mid-2000s. 
A total of 2.5 million deaths have been averted in low- and middle-income countries since 
1995 due to antiretroviral therapy being introduced, according to new calculations by 
UNAIDS. Much of that success has come in the past two years when rapid scale-up of 
access to treatment occurred; in 2010 alone, 700, 000 AIDS related deaths were averted. 
The proportion of women living with HIV has remained stable at 50% globally. There were 
2.7 million new HIV infections in 2010, including an estimated 390, 000 among children. 
This was 15% less than in 2001, and 21% below the number of new infections at the peak 
of the epidemic in 1997. The number of people becoming infected with HIV is continuing to 
fall, in some countries more rapidly than others. HIV incidence has fallen in 33 countries, 
22 of them in sub-Saharan Africa, the region most affected by the AIDS epidemic. The 
number of new infections has been falling worldwide yet the prevalence rate of HIV is still 
high. During this same time, the availability of antiretroviral drug therapy has increased the 
survival rate of people living with HIV (UNAIDS 2010: 22). 
 
2.3 HIV AND AIDS IN SUB SAHARAN AFRICA 
 
Sub-Saharan Africa remains the region most heavily affected by HIV. In 2010, about 68% 
of all people living with HIV resided in sub-Saharan Africa, a region with only 12% of the 
global population. Sub-Saharan Africa also accounted for 70% of new HIV infections in 
2010, although there was a notable decline in the regional rate of new infections. The 
epidemic continues to be most severe in southern Africa, with South Africa having more 
people living with HIV (an estimated 5.6 million) than any other country in the world. Almost 
half of the deaths from AIDS-related illnesses in 2010 occurred in southern Africa. AIDS 
has claimed at least one million lives annually in sub-Saharan Africa since 1998. Since 
then, however, AIDS-related deaths have steadily decreased, as free antiretroviral therapy 
has become more widely available in the region. The total number of new HIV infections in  
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sub-Saharan Africa has dropped by more than 26%, down to 1.9 million from the estimated 
2.6 million at the height of the epidemic in 1997. In 22 sub-Saharan countries, research 
shows HIV incidence declined by more than 25% between 2001 and 2009 (UNAIDS 2011: 
7). 
The recent regional HIV and Aids statistics shows that there are 23.5 million (22.2 million-
24.7 million) adults and children living with HIV, 1.7 million adults and children newly 
infected with HIV, 1.2 million adult and child death due to AIDS and 4.8% adult prevalence 
of HIV in sub Saharan Africa in 2011 (UNAIDS 2012: 2-4).  
 
2.4 HIV AND AIDS IN ETHIOPIA 
  
In Ethiopia the first two AIDS cases were reported in 1986. Since then, the prevalence rate 
has continuously increased until the year 2000 when it begun to show some decline (Merso 
2007/8: 36). According to Ethiopia’s 2007 single point estimates, the national adult (ages 
15-49 years) HIV prevalence for 2008 is 2.2% (male 1.8% and female 2.6%), with an urban 
and rural HIV prevalence of 7.7 percent and 0.9 percent, respectively. Since the first two 
reported AIDS cases in 1986, deaths have spread at an alarming rate throughout the 
country (FMOH/FHAPCO, 2007: 44). As the single point estimate shows, HIV prevalence 
in urban Ethiopia is nearly nine times higher than in rural areas. This finding is consistent 
with 2006 antenatal surveillance (FMOH and FHAPCO 2006 and 2007) and the 2005 
Ethiopia Demographic and Health Survey (Central Statistical Agency and Macro 
International 2006: 238). In terms of current HIV epidemiology, prevalence data indicate a 
far less generalized epidemic in Ethiopia than previously believed. The epidemic is 
concentrated in urban and peri-urban areas and more prevalent among women than men. 
The nature of the epidemic in Ethiopia, therefore, calls for targeted HIV and Aids 
interventions (FHAPCO and World Bank 2008: 29). The same report estimated that there 
are 1,037,267 people living with HIV (PLHIV) in the country, of which 289,734 are in need 
of antiretroviral treatment (ART). In 2008, 886,820 children below the age of 17 have lost 
one or both of their parents to HIV and Aids. 
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The HIV epidemic in Ethiopia is generally considered to be high, with increasing levels of 
economic hardship, expanding urbanisation, increased mobility due to labour migration, a 
history of conflicts and civil disruption, and better educational and trading opportunities 
facilitating the spread. Conducting research and disaggregating data to the district level in 
order to identify population groups at higher risk are mandatory to expand services such as 
VHCT, treatment of sexually transmitted infections, antenatal and postnatal prevention of 
mother to child transmission (PMTCT), TB/HIV integration, and services targeted to 
specific populations, including youth, students, sex workers, migrants, refugees and other 
displaced populations, and the uniformed services (The World Bank 2008: 49).  
  
2.5 GLOBAL TB INFECTION 
 
One third of the world’s population is infected by Mycobacterium tuberculosis, the 
bacterium that causes TB. There were an estimated 9.2 million new TB cases and 1.5 
million TB deaths in 2006, including 0.2 million deaths among people infected with HIV. TB 
remains a major cause of morbidity and mortality in many countries and a significant public 
health problem worldwide. The global incidence of TB was estimated to be 139 cases per 
100,000 in 2006. Ninety-five percent of these cases and 98 percent of TB deaths occur in 
developing countries, affecting mostly (75 percent) persons in the economically productive 
age group (15–50 years) (Dara et al 2009:13). 
 
In 2008, there were an estimated 9.4 (range, 8.9-9.9 million) million incident cases 
(equivalent to 139 cases per 100,000 population) of tuberculosis (TB) globally. This is an 
increase from the 9.3 million TB cases estimated to have occurred in 2007, as slow 
reductions in incidence rates per capita continue to be outweighed by increases in 
population. Most of the estimated number of cases in 2008 occurred in Asia (55%) and 
Africa (30%), with small proportions of cases in the Eastern Mediterranean Region (7%), 
the European Region (5%) and the Region of the Americas (3%). The 22 high-burden 
countries (High-Burden Countries, defined as the countries that rank first to 22nd in terms 
of absolute numbers of cases and which have received particular attention at the global 
level since 2000) account for 80% of all estimated cases worldwide (Nigatu & Abraha 
2010:376). 
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TB is the leading cause of death among people living with HIV. Almost one in four deaths 
among people with HIV is due to TB. In 2009, 380,000 people died of HIV-associated TB 
worldwide. It is also the most common presenting illness among people living with HIV, 
including those who are taking antiretroviral treatment. There was an estimated 1.1 million 
HIV positive TB patients globally in 2009 and 80% of the patients live in sub-Saharan 
Africa.  At least one-third of the 33.3 million people living with HIV worldwide are infected 
with TB. Persons co-infected with TB and HIV are 20-30 times more likely to develop active 
TB disease than persons without HIV (WHO 2010: 1). 
 
According to WHO (2011: 1), the number of people who fell ill with TB dropped to 8.8 
million in 2010, including 1.1 million cases among people with HIV. The number has been 
falling since 2005. The estimated global incidence rate fell to 128 cases per 100,000 
populations in 2010, after an increase in 2002 at 141 cases per 100,000. The rate is falling 
but very slowly. The number of people who died from TB fell to 1.4 million in 2010.  
  
  
2.6 TB IN AFRICA 
 
The burden of TB in sub-Saharan Africa is far greater today. Continuing poverty and 
political instability in parts of the continent has inhibited the progress in implementing 
effective TB control measures. Southeast Asia has the highest number of new 
Tuberculosis (TB) infection annually, but sub Saharan Africa has a TB incidence rate 
double that of Southeast Asia and the highest number of TB related deaths in the world as 
well as the highest per capita TB mortality. South Africa and Nigeria have the fourth and 
fifth largest numbers of new TB cases annually; however, South Africa, has the highest 
prevalence, incidence, and death rate per capita worldwide (Jennifer 2009: 4-5). 
 
In sub-Saharan Africa, the number of new TB cases continues to rise at 3–5 percent per 
year despite the DOTS program until around 2005, and the efforts to control the disease 
are challenged by the problem of co-infection with HIV. In 2003, 33 percent of new TB 
cases in this region were adults who were also infected with HIV, that is approximately 12 
million adults co-infected with TB and HIV (World Bank 2008: 28-29). 
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2.7 TB IN ETHIOPIA 
 
Ethiopia has a total population of above 80 million with 86.2% living in the agrarian regions 
[Oromiya, Amhara, Southern Nations Nationalities and Peoples Region (SNNR) and Tigray 
regions]. The rest 9.2% and 4.6% live in the pastoral areas of Gambella, Somali, 
Benshangul-Gumuz and Afar regions, and urban Addis Ababa, Diredawa and Hareri 
(Central statistical authority, 2007). Ethiopia ranks seventh among the world’s 22 high-
burden TB countries. The country had an estimated 306,330 TB cases in 2006, with an 
estimated incidence rate of 379 cases per 100,000 population. The Stop TB Strategy is the 
approach recommended by WHO to reduce the burden of TB in line with global targets set 
for 2015 (WHO 2008: 105-108). 
 
2.8 TB/HIV COINFECTION 
 
Worldwide, tuberculosis is the most common cause of death among patients with AIDS, 
killing 1 of every 3 patients (Raviglione et al 1995: 220-226). The lifetime risk of 
tuberculosis in immune competent persons is 5% to 10%, but in HIV positive individuals, 
there is a 5% to 15% annual risk of developing active TB.  Tuberculosis is the leading 
cause of death in HIV positive individuals accounting for approximately one-third of AIDS 
deaths in the developing world and 11% of AIDS deaths worldwide (Swaminathan et al 
2000: 839-844). 
Ethiopia was among the first few African countries to introduce ART in 2003, in selected 
health facilities following the issuance of the national antiretroviral drugs (ARVs) supply and 
use policy in 2002. The Ethiopian free ART scheme was launched in 2005 (FMOH 2007: 
14). 
The introduction of provider initiated testing and counselling in most public health facilities 
has improved HIV screening among TB patients from 16% in 2007 to 38% in 2009. A total 
of 56,040 TB patients were tested for HIV, of which 11,118 (20%) were found to be HIV 
positive. In addition, a total of 24,112 HIV-positive people were referred from HCT, chronic 
HIV and ART clinics for TB screening out of which 4,154 (17.2%) were found to have active 
TB and 2,403 (10%) with latent TB, and hence put on IPT. The proportion of HIV-positive 
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patients who were screened for TB increased from 25% in 2007 to 55% in 2009. 
Furthermore, in the fiscal year July 2008 through June 2009, 68% of HIV-positive patients 
with TB were put on Cotrimoxazole prophylaxis therapy (CPT) and 41% had started ART 
(FHAPCO 2010: 49-50) 
The Ethiopian Federal HIV/AIDS Prevent ion and Control Office (FHAPCO 2010: 53-54) 
reports that TB indicators remained stable between 2008 and 2009, with TB case detection 
rate at 34% (below the national target of 67.8%). TB treatment success rate was at 84% 
and those successfully treated were 67% in the year 2008. These indicators have shown a 
gradual increase over the past ten years. In 2009, 33,069 new sputum smear positive TB 
cases were detected. The report also showed that the number of TB  cases detected were  
way below the planned target, which was due to a combination of factors that includes lack 
of integration of TB case finding  in all out patient departments (OPDs) of health facilities as 
part of PICT, the  lack of stronger involvement of Health Extension Workers (HEWs), lack 
of provision of services by some health facilities, inadequate training and supervision on 
improvement of TB success rate with less emphasis on detection rate, lack of functional 
laboratories in many health facilities, and inadequate skill of some laboratory technicians 
on how to do proper microscopic examination using the Acid Fast Bacilli (AFB) staining.  
Unfortunately, knowledge of the real extent of TB/HIV co-infection is limited due to 
insufficient surveillance data. However, there are a lot of risk factors contributing for the 
occurrence of TB co-infection in HIV and Aids patients including contact with active cases 
of pulmonary TB, coexisting risk factors and vulnerability factors such as injecting drug use, 
alcohol abuse and incarceration (WHO 2006:136-137). 
According to Mohammed et al (2011:131-139), determinants of active Tuberculosis in 
HIV/AIDS patients include factors such as socio-economic status which include ownership 
of house, income, residence, marital status, occupation and education. There are also 
proximate determinants which include the age, sex, previous history of TB, WHO staging, 
infection with helminthes and Body Mass Index (BMI). Environmental factors like number of 
rooms, crowding, waste disposal, type of house, and presence of separate kitchen also 
contribute to the occurrence of TB co-infection in HIV and Aids patients. However, this 
study was not able to differentiate the risk factors among HIV and Aids patients who were 
on ART and those who were not. 
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2.9 CONCLUSION 
 
The chapter on literature review presented and discussed HIV and Aids, TB, and TB/HIV in 
global, sub Saharan Africa and Ethiopian context. It also presented and discussed risk 
factors causing TB co-infection among HIV and Aids patients on antiretroviral therapy 
(ART). The study tried to explore different socioeconomic, demographic, environmental, 
and behavioral factors related to TB and HIV co-infection.  
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CHAPTER 3 
RESEARCH METHODOLOGY 
 
3.1 INTRODUCTION 
 
This chapter describes research methods, research design, population and sample 
selection, data collection, data collection tools and procedures, reliability of the research 
instrument, criterion-related validity, data entry and analysis. The chapter also discusses 
ethical considerations and provides conclusions. 
3.2 RESEARCH DESIGN 
 
The research design is an overall plan for addressing a research question, including 
specifications for enhancing the study’s integrity (Polit & Beck 2008: 765). The research 
design involves a plan, structure and strategy of the study. These three research design 
concepts guide a researcher in writing the research questions, conducting the project, and 
in analysing and evaluating the data (Haber & Lobiondo-Wood 2006:202). 
Research design is the structured approach followed by researchers to answer a particular 
research question. It is also the architecture of the study, because the choice of the study 
design determines how we sample the population, collect measurements and analyze the 
data (Joubert & Ehrlich 2007:77). The quantitative approach provides a method to collect 
statistical data for analysis and reporting. The main purpose of a scientific research is to 
explore the association among primary variables in an effort to gain a better understanding 
of the phenomena under study (Haber & Lobiondo-Wood 2006: 206). 
This study employs an observational analytic case control study design to assess risk 
factors associated with TB co-infection in HIV and Aids patients taking ART in Nekemte 
hospital, Western Ethiopia.  
3.2.1 Rationale for choosing quantitative paradigm 
This design was chosen because quantitative paradigm tends to measure numeric 
information using structured questionnaire. It emphasizes objectivity in the collection of 
data and analysis of information. Data will be analysed through statistical procedures (Polit 
and Beck 2008: 14-17; Burns and Groves 2005: 23-24). 
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3.2.2 Observational Study Design 
Observational study design is a kind of research design that does not involve experimental 
intervention. It is a study in which data are collected through direct observation (Polit & 
Beck 2008: 760). In an observational study, the researcher measures exposures and 
outcomes without any personal intervention or manipulation of the research context so that 
the outcomes that occur are actually a product of the natural setting in which the 
phenomena are located (Morroni & Myer 2007: 77). 
3.2.3 Analytic research Design 
A study design in which the association between two variables is studied is called an 
analytical research design (Morroni & Myer 2007: 78).The purpose of an analytical 
research design is therefore to identify the factors that predict or cause a disease or a 
predetermined condition by examining the relationships that obtain between independent 
and dependent variables (Morroni & Myer 2007: 78). 
3.2.4 Case control research design  
A case control study design is a non-experimental study design involving the comparison of 
a case, that is, (a person with the condition under scrutiny) and a control (a person without 
a condition) (Polit & Beck 2008: 748). 
3.3 RESEARCH METHODS 
  
Research methods are techniques researchers use to structure a study and to gather and 
analyze information relevant to a research question (Polit & Beck 2008: 15).This section 
describes the study setting, population, sample and sample size, method of data collection, 
and data analysis. 
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3.3.1 Study Setting and Period   
The study was carried out in one of the public health facilities in Nekemte town, East 
Wollega Zone Oromia region, West Ethiopia. 
Nekemte town is found in Western part of Oromia which is 331kilometers away from Addis 
Ababa. The town has six sub cities. According to Nekemte town municipality statistics 
office, the total population of the town in 2008/9 was 90,605. Among these 44,396 are 
males and 46,209 are females. There are 5 governmental health institutions (1 hospital, 2 
health centres, and 2 pharmacy), 8 nongovernmental (1 health centre, 2 medium and 2 
junior clinics, 1 eye clinic, and 1 drug store), and about 44 private owned health institutions 
(4 higher, 7 medium, and 14 junior clinics, 1 dental clinic, 3 pharmacies, 6 drug stores, 3 
wholesalers, and 5 rural drug vendors). 
Nekemte Hospital serves more than 2 million people as a referral hospital in the Western 
Oromia providing the community with different preventive, curative and rehabilitative health 
service. The duration of the study was from June 2012 to September 2012. 
3.3.2 Target (Study) Population 
 
Polit and Beck (2008:767) describes target population as the entire population in which a 
researcher is interested and to which he or she would like to generalize the study results. 
The target population of this study are all adults above 18 years of age who are: (i) infected 
with HIV and Aids, (ii) HIV positive patients co infected with TB and (iii) HIV positive 
patients not co infected with tuberculosis but are currently taking antiretroviral therapy from 
Nekemte hospital.  
3.3.3. Sample 
 
Polit and Beck (2008: 765) pointed out that a sample is a subset of a population selected to 
participate in a study. Selecting a sample from total population has many reasons such as 
economy, timeliness, the large size of many populations, inaccessibility of some of the 
population, destructiveness of the observation and accuracy.  
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3.3.3.1 Sampling procedure 
  
According to Polit and Beck (2008: 765), sampling is a procedure of selecting a portion of 
the population to represent the entire population.  Simple random sampling is, a basic 
probability sampling technique which involves random selection of participants from a 
sampling frame. In this study simple random sampling was used to select the total number 
of patients/participants that were required for the study. This sampling technique allows the 
researcher to generalize the results of the study to the target population and each 
individual in the population has equal an chance of being included in the sample. Sampling 
frame is a list or some representation of a study population, either of individuals or of 
groups of individuals (Joubert & Ehrlich 2007: 95). For this study, the sampling frame was 
obtained from the database of Nekemte hospital registration book for all patients who are 
on antiretroviral therapy.  
3.3.3.2 Sampling Criteria 
 
In this study, the following inclusion criteria were used/applied: 
• Participants who were 18 years of age and above 
• Participants who have been on antiretroviral therapy for at least one year. 
• Participants who were either co infected or not co infected with TB. 
•  Participants who were willing to give their informed consent to participate in the 
study.   
 
The exclusion criteria include participants:  
• Less than 18 years  
• Mentally disabled 
• Who had opportunistic infection (other than TB) or known chronic illness like 
diabetes mellitus, cardiovascular disease or hypertension.  
• Had prior history of TB ( who are currently not active TB patient) 
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3.3.3.3 Sample Size 
  
Sample size is the number of respondents who are necessary for the achievement of a 
statistically valid conclusion (Polit & Beck 2008: 348). This requirement dictates the 
minimum number of participants who have to be included in the sample. The sample size 
was calculated by Epi-Info 2 using two sample proportion formulae. The calculation is 
based on the 0.05 alpha level, 80% statistical power, 3:1 ratio of controls to cases, and 2.0 
desired OR level and 5% non-response rate. Therefore, 92 cases and 275 controls will be 
included in the study with a total sample size of 367. 
 
3.4 DATA COLLECTION 
  
Data collection was carried out in the health institution by training nurses who work in ART 
and TB clinics using a standard questionnaire after obtaining informed consent from each 
participant. The objective of the study was explained to each participant and the data 
collection was conducted in a private room up on client exit. Data collection was supervised 
by the investigator on a regular basis. The participants did not need to be literate. In 
addition, personal contact can facilitate the response and quality information (Joubert & 
Ehrlich 2007:108).   
3.4.1 Data collection instrument 
 
A structured questionnaire was used to gather information concerning risk factors of 
tuberculosis co-infection among HIV and Aids patients who are taking antiretroviral 
therapy. The questionnaire was designed to gather socio demographic characteristics, 
social conditions, health seeking behaviour, knowledge about TB/HIV and risk behaviours 
among research participants. 
3.4.2 Reliability of data collection instrument 
 
Reliability refers to the degree to which a data collection instrument provides consistent 
information. It is also concerned with the instrument’s stability and accuracy (Polit and Beck 
2008: 416-420). The reliability of a research instrument refers to the precision and 
accuracy with which a test is able to obtain the data for which it was designed even if the 
research instrument is used again and again (Myer & Karim 2007: 155).  
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In order to keep the reliability of data collection instrument, the researcher carefully 
designed the questionnaire and trained the field workers about data collection instrument 
and process. The research instrument was tested in a health facility where the study was 
not conducted and necessary adjustments were made in the data collection instrument. 
The researcher was supervising the data collection process and was correcting any issues 
that raised during the data collection period.    
3.4.3 Validity of data collection instrument 
 
Validity refers to the certainty of a data collection instrument to measure what it is 
supposed to measure in the context it is used.  The validity of research instrument refers to 
how accurate a research instrument measures what it is supposed to measure (Myer & 
Karim 2007: 156).  In this study, a questionnaire was designed to measure the risk factors 
associated with TB co-infection. After pre-test of the data collection instrument, the 
feedback from the pre-test is incorporated to the actual data collection instrument. In 
addition, to address the issue of face and content validity, the researcher has attempted to 
determine whether the content of the questionnaire has adequately addressed the 
research topic. 
3.4.4 Pre testing of data collection instrument  
 
After translating the data collection instrument in to the local language, the researcher 
undertook pre test on 30 respondents; that is 20 patients not co infected with TB and 10 
patients co infected with TB in a health centre which provides ART service and which was 
not part of the study. During pre-test the questionnaire was checked for its clarity, 
simplicity, comprehensiveness and coherence. Based on the results obtained from the pre-
test, corrections were made to the questionnaire. The comments raised as limitations and 
wording problems during the pre-test were corrected and incorporated to the final 
questionnaire in addition to the comments given by the researcher’s colleague. Finally 
there was little change on part three of the questionnaire.  
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3.4.5 Data Collection Procedure 
 
Training was given to all field workers (nurses working in the TB/HIV clinic) before the start 
of data collection process. The questionnaire was prepared in English then translated to 
local language (Afan Oromo) and again back to English to check for its consistency. Before 
the actual data collection process took place, the data collection instrument was pre-tested 
in another health institution. The data collectors read the consent to the respondents and 
after signing the consent the respondents were asked questions to respond to the 
questionnaire by field workers.  
 
3.5 ETHICAL CONSIDERATION  
 
Joubert and Ehrlich (2007: 30) define ethics as a theory or a system of moral values and 
rules or standards governing the conduct of a person or the members of a profession.    
3.5.1 Ethical clearance and Informed Consent 
 
Ethical clearance was obtained from Higher Degrees Committee of the Department of 
Health Studies of the University of South Africa with a certificate no. HSHDC/62/2012.  
Institutional consent was gained from East Wollega zone Health Bureau and Nekemte city 
health office (Ref: 19102/WEFN/2004) to conduct the study and to seek support of health 
professionals of the selected health facility where the study was conducted. 
 
The Belmont Report articulated three main ethical principles on which standards of ethical 
conduct in research are based: beneficence, respect for human dignity, and justice (Polit& 
Beck 2008: 170). In addition to this, main ethical principles that were adopted in this study 
are discussed below. 
3.5.2 Specific Ethical Issues  
  
In relation to the research topic (Risk Factors associated with TB co-infection in HIV and 
Aids patients on antiretroviral therapy (ART), research methodology and the design), the 
ethical issues addressed in this study are presented as follows. 
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Autonomy: Is negotiating and acting under the direction of the negotiation (Joubert & 
Ehrlich 2007: 32).  Individuals have the right to choose and thus the right to know about the 
personal consequences of joining a study. In this study, participants were informed about 
the right to decide voluntarily whether to participate in a study or not and were informed 
that there will not be any risk or penalty prior to the data collection. 
Informed consent: Involves giving participants adequate information regarding the 
research to enable them to comprehend the information, and have the power of free 
choice, enabling them to voluntarily consent to or decline participation (Polit & Beck 2008: 
176). Both verbal and written informed consent were obtained from the study participants 
before they were interviewed by the data collectors. 
Beneficence: Is the ethical obligation to maximize benefits of the study participants and to 
prevent harm (Polit & Beck 2008: 170). Participants in this research were treated well, the 
research was aimed at producing results beneficial to humankind; in this case HIV positive 
patients. The interview was scheduled and designed carefully to prevent any psychological 
discomfort. 
Confidentiality: confidentiality is a pledge that any information obtained from participants  
will not be publicly reported in a manner that identifies them and will not be made 
accessible to others (Polit & Beck 2008: 180). Confidentiality and anonymity of the 
participants and their information was secured by using codes and not the patient’s names 
throughout the study, so that the respondents would not be identifiable. The questionnaires 
were also kept in a secure place where only the researcher could access them.    
Non-maleficence: participating in the study did not cause any harm to the participants 
because the data collection instrument was carefully designed and data collectors were 
health professionals who were trained (Joubert & Ehrlich 2007: 32-33). 
Justice: Is the right to fair treatment and the right to privacy (Polit & Beck 2008: 173). 
Simple random sampling was used to select respondents so that they are selected fairly. 
Participant’s privacy was ensured throughout the study by conducting the interview in a 
private room. 
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3.6 DATA ENTRY AND ANALYSIS 
  
Data were entered and cleaned by running frequency of the variables using statistical 
package for social science (SPSS) for windows version 16.0. Frequency of dependent 
variables was illustrated by cross tabulation with the outcome variable. A 2x2 table was 
constructed and an odds ratio of 95% confidence interval was calculated to measure the 
association and test statistical significance. The results are illustrated in the form of 
frequency tables and depicted graphically in order to provide an overview of the findings. 
3.7 LIMITATIONS OF THE STUDY 
Since the exposure status of patients are assessed after occurrence of disease in a case 
control studies, case control studies that rely on interview such as this study are vulnerable 
to recall bias. This means that, even though the questionnaire was structured, the actual 
risk factors that the respondents reported might have been different if the questionnaire 
was self-administered. In this case the questionnaire was read to participants by their 
health care providers. Therefore, one cannot know if risk factors might vary among different 
patients in a different situation. 
3.8 CONCLUSION 
 
This chapter described the research methodology used in this study. It discussed the 
research design, sample, sampling procedure, data collection and its procedures, ethical 
consideration, data entry and analysis, and limitations of the study. 
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CHAPTER 4 
PRESENTATION AND DISCUSSION OF RESEARCH RESULTS 
 
4.1 INTRODUCTION 
  
This Chapter discusses the results that emerged from the data analysis and interpretation 
of those results. Literature that support these findings are also included in this Chapter. 
The findings are presented according to the sequence in the questionnaire and are 
presented according to the following sub-headings: socio-demographic characteristics, 
social conditions, health seeking behaviour, knowledge and risky behaviour. 
The purpose of this study was to assess risk factors associated with TB co-infection among 
HIV and Aids patients taking ART in randomly selected cases (patients who are confirmed 
of having tuberculosis) and controls (patients who do not have tuberculosis) in Nekemte 
hospital of Oromia region, Western Ethiopia. 
The Objectives of the study were: 
• To determine the socio demographic risk factors associated with TB co-infection in 
HIV and Aids patients taking antiretroviral therapy in Nekemte Hospital, Western 
Ethiopia. 
• To identify behavioural and economic risk factors associated with TB co-infection in 
HIV and Aids patients taking antiretroviral therapy in Nekemte Hospital, Western 
Ethiopia. 
• To assess knowledge on TB co-infection among HIV and Aids patients taking 
antiretroviral therapy in Nekemte Hospital, Western Ethiopia. 
 
In this study, data were collected from all 367 respondents (92 cases and 275 controls) 
were analysed using a Microsoft Software Package called the Statistical Package for 
Social Science (SPSS) version 16.0. 
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4.2 SOCIO-DEMOGRAPHIC CHARACTERISTICS 
 
This section presents data on the age, sex, religion, ethnicity, marital status, educational 
status, occupational status and residence of respondents.  
Based on the result gained from the respondents during the time of interview, Table 1 
below depicts the summary of the socio-demographic variables of all 367 respondents 
which include age, sex, religion, ethnicity, marital status, educational status, occupational 
status, and residence.   
Table 4.1: Socio-demographic characteristics and TB co-infection in HIV and Aids 
patients taking ART, Western Ethiopia, 2012 (N=367). 
Variables Cases 
N (%) 
Controls 
N (%) 
P- Value 
Age 
     18-22 
     23-27 
     28-32 
     33-37 
     38-42 
     43-47 
     Total 
 
6 (6.5) 
10 (10.9) 
26 (28.3) 
14 (15.2) 
18 (19.6) 
18 (19.6) 
92 (100) 
 
10 (3.6) 
42 (15.3) 
76 (27.6) 
68 (24.7) 
46 (16.7) 
33 (12.0) 
275 (100) 
 
0.14 
Sex 
     Male 
     Female 
     Total 
 
44 (47.8) 
48 (52.2) 
92 (100) 
 
132 (48.0) 
143 (52.0) 
275 (100) 
 
0.97 
Religion 
     Orthodox 
     Muslim 
     Protestant 
     Others 
     Total 
 
47 (51.1) 
12 (13.0) 
28 (30.4) 
5 (5.4) 
92 (100) 
 
131 (47.6) 
27 (9.8) 
114 (41.5) 
3 (1.1) 
275 (100) 
 
0.04 
Ethnicity 
     Oromo 
     Amhara 
     Others  
     Total 
 
61 (66.3) 
18 (19.6) 
13 (14.2) 
92 (100) 
 
222 (80.7) 
47 (17.1) 
6 (2.3)) 
275 (100) 
 
<0.001 
Marital Status 
     Single 
     Married 
     Divorced 
     Widowed 
     Total 
 
14 (15.2) 
44 (47.8) 
18 (19.6) 
16 (17.4) 
92 (100) 
 
33 (12.0) 
155 (56.4) 
36 (13.1) 
51 (18.5) 
275 (100) 
 
0.32 
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Educational Status 
     No formal education 
     Formal education 
     Total 
 
16 (17.4) 
76 (82.7) 
92 (100) 
 
24 (8.7) 
251 (91.3) 
275 (100) 
 
0.02 
Occupational Status 
     Unemployed 
     Employed 
     Total 
 
9 (9.8) 
83 (90.4) 
92 (100) 
 
13 (4.7) 
262 (95.3) 
275 (100) 
 
0.07 
Residence 
     Urban 
     Rural 
     Total 
 
81 (88.0) 
11 (12.0) 
92 (100) 
 
238 (86.5) 
37 (13.5) 
275 (100) 
 
0.71 
 
There were 6.5% of cases and 3.6% of controls who were between 18 and 22 years old; 
10.9% of cases and 15.3% of controls were between 23 and 27 years old; 28.3% of cases 
and 27.6% of controls were between 28 and 32 years old; 15.2% of cases and 24.7% of 
controls were between 33 and 37 years old; 19.6% of cases and 16.7% of controls were 
between 38 and 42 years old; 19.6% of cases and 12.0% of controls were between 43 and 
47 years of age. The figure shows that 80.4% of cases and 88.0% of controls between 18 
and 42 years of age. The mean age of respondents is 33.76. This implies that HIV affects 
mainly those who are most in a productive age group, however; TB co-infection is much 
higher in old age than lower age group. 
The gender distribution of the respondents was 52.2% (n=48) of cases and 52.0% (n=143) 
of controls were Female respondents. This shows that almost equal proportion of Male and 
Female respondents were included in the study.  
Regarding their religious affiliation, 51.1% of cases and 47.6% of controls were Orthodox 
Christians; 13.0% of cases and 9.8% of controls were Muslims; 30.4% of cases and 41.5% 
of controls were Protestants; and 5.4% of cases and 1.1% of controls belonged to the 
category of ‘others’. The majority of respondents in this study were Christians. 
In describing ethnicity of respondents, Oromo consists of 66.3% of cases and 80.7% of 
controls; Amhara contributes to 19.6% of cases and 17.1% of controls; 14.2% of cases and 
2.3% of controls claimed that they belong to the ethnic group categorized as ‘others’.  
Out of the total number of respondents, 15.2% of cases and 12.0% of controls were single 
(never married); 47.8% of cases and 56.4% of controls were married; 19.6% of cases and 
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13.1% of controls were divorced; while 17.4% of cases and 18.5% of controls were 
widowed.  
Respondents disclosed their highest education level they had attained prior to the interview 
as 17.4% of cases and 8.7% of controls had no formal education; and the rest 82.7% of 
cases and 91.3% of controls had formal education of which 45.7% of cases and 38.2% of 
controls had primary (1-8 grade) education; 27.2% of cases and 34.2% of controls had 
secondary (9-12 grade) education; and 9.8% of cases and 16.0% of controls had tertiary 
(12+) education level. These result shows the number of cases who had no formal 
education (17.4%) were twice as the number of controls who had no any formal education 
(8.7%). 
During the time of interview, out of the total number of respondents 9.8% of cases and 
4.7% of controls were unemployed; the rest 90.4% of cases and 95.3% of controls were 
employed of which 33.7% of cases and 16.4% of controls were day labourers (temporary 
employment); 12.0% of cases and 12.7% of controls were housemaid (temporary 
employment); 3.3% of cases and 10.9% of controls were farmers; 28.3% of cases and 
31.3% of controls were private employees; 12.0% of cases and 17.5% of controls were 
government employees; and only 1.1% of cases and 6.5% of controls were NGO 
employees.  
About 88.0% of cases and 86.5% of controls live in urban area while only 12.0% of cases 
and 13.5% of controls were from rural area.  
Figure 4.1 below shows the age category of cases and controls and their TB status. 
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Figure 4.1 Age category and TB result of respondents (N=367) 
 
Similarly, Figure 4.2 shows the marital status of both co infected and not co infected 
patients whether or not their tuberculosis result is affected by the factor. 
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Figure 4.2 Marital status and TB result of respondents (N=367) 
 
4.3 SOCIO-ECONOMIC CONDITIONS  
   
This section assessed the socio-economic conditions of respondents which include 
housing, income, waste disposal and other socio-economic conditions. 
In the analysis of the socio-economic conditions of respondents, there were no significant 
differences between cases and controls concerning most of socio-economic factors such 
as housing conditions, availability of electricity, presence of animals in the house, and also 
occupation.  
Out of the total number of respondents, 75% of cases and 81.8% of controls live in houses 
with 1-3 rooms; 25% of cases and 18.2% of controls live in houses consisting of 4-6 rooms. 
The walls of houses in which 92.4% of cases and 88.4% of controls live were made from 
mud or mud bricks; while 7.6% of cases and 11.6% of controls live in the house made of 
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cement walls. Regarding the availability of a separate kitchen, 15.2% of cases and 18.5% 
of controls had no separate kitchen; the rest 84.8% of cases and 81.5% of controls had a 
separate kitchen. The number of respondents who had no electric service was 15 (16.3%) 
for cases and 44 (16.0%) for controls; while 83.7% of cases and 84% of controls had 
electric service.  
During the time of interview 50% of cases and 26.5% of controls responded that they 
dispose waste inside their own compounds; and the rest 50% of cases and 73.5% of 
controls dispose waste outside their own compound. In describing their income, 72.8% of 
cases and 50.2% of controls reported that their monthly income was below 30USD (US 
Dollar); while the other 27.2% of cases and 49.8% of controls reported that they get a 
monthly income of ≥30USD (US Dollar).    
Table 4.2 below gives summary of socio-economic conditions of all 367 respondents. 
Table 4.2: Socio-economic characteristics and TB co-infection in 
                HIV and Aids patients taking ART, Western Ethiopia, 2012 (N=367). 
Variable Case 
N (%) 
Control 
N (%) 
P-Value 
Number of rooms 
     1-3 rooms 
     4-6 rooms 
     Total 
 
69 (75.0) 
23 (25.0) 
92 (100) 
 
225 (81.8) 
50 (18.2) 
275 (100) 
 
0.35 
People in the room 
     1-5 people 
     6-11 people 
     Total 
 
71 (77.2) 
21 (22.8) 
92 (100) 
 
222 (80.7) 
53 (19.3) 
275 (100) 
 
0.46 
Walls of the house 
     Mud/Mud bricks 
     Cement 
     Total 
 
85 (92.4) 
7 (7.6) 
92 (100) 
 
243 (88.4) 
32 (11.6) 
275 (100) 
 
0.27 
Floor of the house 
     Mud 
     Cement 
     Total 
 
58 (63.0) 
34 (37.0) 
92 (100) 
 
173 (62.9) 
102 (37.1) 
275 (100) 
 
0.98 
Availability of separate kitchen 
     Yes 
     No 
     Total 
 
78 (84.8) 
14 (15.2) 
92 (100) 
 
224 (81.5) 
51 (18.5) 
275 (100) 
 
0.46 
Availability of Electricity 
     Yes 
     No 
 
77 (83.7) 
15 (16.3) 
 
231 (84.0) 
44 (16.0) 
 
0.94 
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     Total 92 (100) 275 (100)  
Do animals in the house 
     Yes 
     No 
     Total 
 
26 (28.3) 
66 (71.7) 
92 (100) 
 
60 (21.8)   
215 (78.2) 
275 (100) 
 
0.20 
Waste disposal system 
     In the compound 
     Outside the compound 
     Total 
 
46 (50.0) 
46 (50.0) 
92 (100) 
 
73 (26.5) 
202 (73.5) 
275 (100) 
 
<0.001 
Monthly income 
     <30 USD 
     ≥30 USD 
     Total 
 
67 (72.8) 
25 (27.2) 
92 (100) 
 
138 (50.2) 
137 (49.8) 
275 (100) 
 
<0.001 
Meals a day 
     1-2 
      ≥3 
     Total 
 
22 (23.9) 
70 (76.1) 
92 (100) 
 
49 (17.8) 
226 (82.2) 
275 (100) 
 
0.2 
How long to health facility 
     <30 minute 
     30min-1hr 
     Half a day 
     One day 
     >one day 
     Total 
 
39 (42.4) 
29 (31.5) 
13 (14.1) 
11 (12.0) 
0 (0.0) 
92 (100) 
 
142 (51.6) 
66 (24.0) 
50 (18.2) 
15 (5.5) 
2 (0.7) 
275 (100) 
 
0.08 
How much it costs you to reach 
 this health facility 
     <1 USD 
     1-2 USD 
     >2 USD 
     Total 
 
 
69 (75.0) 
11 (12.0) 
12 (13.0) 
92 (100) 
 
 
194 (70.5) 
43 (15.6) 
38 (13.8) 
275 (100) 
 
 
0.65 
Anyone infected with TB 
 living in your house 
     Yes 
     No 
     Total 
 
 
19 (20.7) 
73 (79.3) 
92 (100) 
 
 
5 (1.8) 
270 (98.2) 
275 (100) 
 
 
<0.001 
 
Figure 4.3 below shows the income of both cases and controls and whether it affected the 
tuberculosis result of the respondents 
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Figure 4.3 Income and tuberculosis result of respondents (N=367) 
 
On the other hand, the bar chart below depicts the presence of active tuberculosis patient 
in the house of the respondents and whether this had impact on the tuberculosis result of 
both cases and controls. 
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Figure 4.4 History of contact with active tuberculosis patient and their results of TB (N=367) 
 
 
4.4 HEALTH SEEKING BEHAVIOUR, KNOWLEDGE AND RISKY BEHAVIOURS  
 
In describing where the respondent’s seek medical care, 83.7% of cases and 81.1% of 
controls visit government institutions when they get sick; 7.6% of cases and 6.5% of 
controls seek health care services in private institutions when they get sick; 5.4% of cases 
and 12.0% of controls seek care at both government and private clinics and only 3.3% of 
cases and 0.4% of controls reported that they seek health service care in areas accorded 
under the heading of ‘others’. 
Out of the total respondents 27.2% of cases and 2.2% of controls do not take ART 
regularly as prescribed; the rest 72.8% of cases and 97.8% of controls take their drug on a 
regular basis. Sixteen percent of cases and 33.3% of controls disclosed the reasons for not 
taking their drugs on a regular basis as distance from the health facility and drug side 
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effect; while 52.0% of cases and 16.7% of controls gave side effect of the drug as a 
reason. About 4.0% of cases and 16.7% of controls reported other infections as the 
reason. The rest of them stated other reasons for not taking their medications. 
Regarding their substance exposure, 34.8% of cases and 2.9% of controls were exposed 
to smoking; 26.1% of cases and 5.1% of controls were exposed to alcohol; 2.2% of cases 
and 1.1% of controls were exposed to khat chewing; and the rest 37.0% of cases and 
90.9% of controls were never exposed to any type of substance. Out of the total 
respondents, 52.2% of cases and 60.4% of controls pointed out radio, television and health 
workers as a means of information to reach HIV patients.  
Based on the results gained from the patients, the Table 4.3 below depicts the summary of 
health seeking behaviours, knowledge, and risky behaviours of the respondents. 
 
Table 4.3 Health seeking behaviour, Knowledge and Risky behaviours and TB co-
infection in HIV and Aids patients taking ART, Western Ethiopia, 2012 (N=367).  
Variable Case 
N (%) 
Control 
N (%) 
P-Value 
Where you seek medical care 
     Private clinic 
     Gov’t institutions 
     Private and Gov’t clinic 
     Others 
 
7 (7.6) 
77 (83.7) 
5 (5.4) 
3 (3.3) 
 
18 (6.5) 
223 (81.1) 
33 (12.0) 
1 (0.4) 
 
0.09 
When did you begin ART 
     1 year ago 
     2-5 years 
     >5 years 
 
26 (28.3) 
56 (60.9) 
10 (10.9) 
 
59 (21.5) 
173 (62.9) 
43 (15.6) 
 
0.28 
Take ART regularly 
     Yes 
     No 
 
67 (72.8) 
25 (27.2) 
 
269 (97.8) 
6 (2.2) 
 
<0.001 
Reasons for not taking ART regularly 
     When caught a disease 
     Distance to health facility 
     Side effect of drug 
     Others 
     Distance and drug side effect 
 
1 (4.0) 
6 (24.0) 
13 (52.0) 
1 (4.0) 
4 (16.0) 
 
1 (16.7) 
0 (0.0) 
1 (16.7) 
2 (33.3) 
2 (33.3) 
 
0.06 
Seek care in past 5 years, not for ART 
     Once a year 
     ≥2 in a year 
     Twice in past 5 years 
     Once in past 5 years 
     Never in past 5 years 
 
23 (25.0) 
46 (50.0) 
3 (3.3) 
2 (2.2) 
18 (19.6) 
 
97 (35.3) 
80 (29.1) 
22 (8.0) 
10 (3.6) 
66 (24.0) 
 
0.008 
36 
 
How can a person prevent TB? 
     Drug/Prophylaxis 
     Balanced diet 
     Immunization 
     Others 
     Drug, diet and Immunization 
     Drug and diet 
     Diet and Immunization 
 
17 (18.5) 
29 (31.5) 
10 (10.9) 
6 (6.5) 
5 (5.4) 
20 (21.7) 
5 (5.4) 
 
127 (46.2) 
20 (7.3) 
31 (11.3) 
11 (4.0) 
42 (15.3) 
36 (13.1) 
8 (2.9) 
 
<0.001 
 
 
 
Can TB be cured? 
     Yes 
     No 
 
91 (98.8) 
1 (1.1) 
 
271 (98.5) 
4 (1.5) 
 
0.79 
Substance you exposed to 
     Smoking 
     Alcohol 
     Khat Chewing 
     Not exposed at all   
 
32 (34.8) 
24 (26.1) 
2 (2.2) 
34 (37.0) 
 
8 (2.9) 
14 (5.1) 
3 (1.1) 
250 (90.9) 
 
<0.001 
Knowledge of opportunistic infections 
     Yes 
     No 
 
67 (72.8) 
25 (27.2) 
 
208 (75.6) 
67 (24.4) 
 
0.59 
How does community treat HIV pts 
     Most reject them  
     Most are friendly but suspicious 
     Support them 
 
50 (54.3) 
25 (27.2) 
17 (18.5) 
 
116 (42.5) 
91 (33.1) 
68 (24.7) 
 
0.12 
Should HIV pts be concerned about 
TB? 
     Yes 
     No 
 
 
90 (97.8) 
2 (2.2) 
 
 
262 (95.3) 
13 (4.7) 
 
 
0.28 
   
Figure 4.5 below presents data on how regular participants take their ART medication and 
its impact on tuberculosis result. 
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Figure 4.5 Taking ART on regular basis and tuberculosis result of respondents (N=367) 
 
 
4.5 UNIVARIATE ANALYSIS OF FACTORS ASSOCIATED WITH TB CO-INFECTION 
 
As presented above in the tables, there was no significant difference between cases and 
controls concerning socio-demographic variables, socio-economic status, health seeking 
behaviour, knowledge and risky behaviours. However, a higher proportion of Orthodox 
Christians and Muslims (p=0.04) had developed tuberculosis compared to other religious 
groups. Oromo and Amhara ethnic groups (p<0.001) were more likely to have tuberculosis 
than the rest of other ethnic groups. A higher proportion of illiterate people (p=0.02) had 
active TB compared to those who attended formal education. Waste disposal inside the 
compound was more common among cases than controls (p<0.001). Individuals whose 
monthly income was less than 30USD are more likely to develop tuberculosis than 
individuals whose monthly income is more than 30USD (p<0.001). A higher proportion of 
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cases lived with a patient infected with active tuberculosis together in the same house or 
had a contact history with a patient of active tuberculosis than those control groups 
(p<0.001). More cases do not take their ART drug as prescribed by a physician on a 
regular basis compared to the control groups (p<0.001). Similarly a larger number of cases 
has visited or sought health care services two or more times in the past five years for a 
reason of different infections  other than taking ART when compared with a control groups 
(p=0.008).  A higher proportion of cases reported a balanced diet as the only measure to 
prevent tuberculosis compared to the control group (p<0.001). In addition a large number 
of cases had a history of substance exposure including smoking, alcohol, and khat 
compared to the control group (p<0.001). However, there was no significance difference 
between cases and controls concerning gender, marital status, residence, walls of the 
house, floor of the house, availability of electricity, presence of animals in the house, 
distance from the health facility, the time they began ART, and their knowledge of 
opportunistic infections (Tables 4.1-4.3).           
4.6 FACTORS INDEPENDENTLY ASSOCIATED WITH TB CO-INFECTION 
 
The final model was constructed using forward stepwise logistic regression. Variables with 
a significant association in the analysis (p<0.05) and those related to the objectives of the 
study such as educational status, waste disposal, monthly income, presence of TB infected 
person in the house or contact with active TB patient, taking ART regularly, knowledge of 
how to prevent tuberculosis and substance exposure were included in the final logistic 
regression.  
 
After adjustment for potential confounders Educational status, waste disposal, monthly 
income, history of contact with infected TB patient, taking ART regularly, knowledge how to 
prevent TB and exposure to substance were independently associated with the occurrence 
of TB co-infection in HIV and Aids patients taking ART. As presented in a table below, 
having formal education (OR=2.61; 95%CI: 1.13, 5.22), waste disposal outside the 
compound (OR=2.75; 95%CI: 1.61, 4.69), monthly income >30USD (OR=2.09; 95%CI: 
1.20, 3.64), no contact history of TB patient in a family (OR=15.31; 95%CI: 5.28, 44.37), 
taking ART on a regular basis as prescribed (OR=24.84; 95%CI: 7.32, 84.22), knowing 
how to prevent TB with a drug or prophylaxis (OR=6.07; 95%CI: 1.04, 35.37), and no 
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exposure to substance like smoking (OR=36.80; 95%CI: 12.88, 105.13) were 
independently protective of the development of active tuberculosis in HIV and Aids patients 
taking ART.  
 
Table 4.4: Factors associated with TB co-infection in HIV and Aids 
                 patients taking ART (N=367). 
Variables Crude OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Educational status 
     No formal education 
     Formal education (1-12+) 
 
1 
2.20 (1.1,4.3) 
 
1 
2.6 (1.3,5.2) 
Waste  disposal 
     In the compound 
     Outside the compound 
 
1 
2.76 (1.6,4.5) 
 
1 
2.75 (1.6,4.6) 
Monthly Income 
     <30USD 
     ≥30USD 
 
1 
2.66 (1.5,4.4) 
 
1 
2.0 (1.2,3.6) 
Presence of TB infected patient in the family 
     Yes 
     No 
 
1 
14.05 (5.0,38.9) 
 
1 
15.3 (5.2,44.3) 
Taking ART regularly 
     Yes 
     No 
 
16.72 (6.5,42.4) 
1 
 
24.84 (7.3,84.2) 
1 
How can a person prevent TB 
     Drug/Prophylaxis 
     Balance diet 
     Immunization 
     Others 
     Drug, balanced diet and immunization 
     Drug and diet 
     Diet and Immunization 
 
4.66 (1.3,15.3) 
0.43 (0.1,1.5) 
1.93 (0.5,7.2) 
1.14 (0.2,5.1) 
5.29 (1.2,22.4) 
1.12 (0.3,3.9) 
1 
 
6.07 (1.0,35.3) 
0.39 (0.0,2.2) 
1.69 (0.2,10.7) 
0.82 (0.1,6.4) 
4.99 (0.6,36.2) 
1.42 (0.2,8.4) 
1 
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Substance exposure 
     Smoking 
     Alcohol 
     Khat 
     No exposure to substance 
 
1 
2.33 (0.8,6.4) 
6.00 (0.8,42.1) 
29.41 (12.5,69.05) 
 
1 
2.47 (0.7,8.3) 
25.7 (1.4,47.5) 
36.8 (12.8,105,1) 
  
In this study, several risk factors of TB co-infection in HIV and Aids patients taking ART 
were investigated in the selected health institution in West Ethiopia. Among these 
determinants, educational status was significantly associated with the development of 
active TB which is consistent with reports in Pakistan (Hussain et al 2003: 794-799). The 
findings of this study also showed that those individuals with formal education were highly 
protected from the development of active tuberculosis than those patients with no formal 
education or illiterate and this is also consistent with a study in India (Shetty et al 2006: 80-
86). 
 
Several studies have shown that socio-economic status is a strong risk factor for the 
occurrence of tuberculosis like Lopez De Fede et al (2008: 1425-1430) and Muniyandi & 
Ramachandran (2008:9(10):1623-1628). In this study, waste disposal and monthly income 
are socio-economic risk factors that are associated with the development of tuberculosis in 
HIV and Aids patients. However, in Ethiopia, the estimation of income based on salaries 
may not reflect the actual income of individuals. The result on the socio-economic risk 
factors was again in support of Mackenbach et al (2008: 2468-2481). There are several 
reasons as to why patients taking ART are more protected from developing active 
tuberculosis such as the increase in body defence mechanism.  
 
Being in contact with an active TB patient was one of the most important predictors of 
active TB. This shows that people who had no contact history with active TB patients were 
more protected from developing active TB than those who had a contact history. This result 
is consistent with Lienhardt et al (2003: 448-455) and Hill et al (2006: 156).  
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The role of smoking in the development of active tuberculosis is well established. 
Individuals who had no history of smoking were much safer than those who had a history of 
smoking. However, there is a social desirability bias whereby smokers deny their smoking 
status, the result of this study is consistent with Ariyothai et al (2004: 219-227) and Lin et al 
(2009: 475-480).       
    
 4.7 CONCLUSION 
 
This Chapter discussed the results and interpretation of data analysis with reference to the 
literature review. The results were presented in the form of tables and charts. 
The next Chapter present conclusions, discuss limitations, and make certain 
recommendations for further research.  
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CHAPTER 5 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIIONS 
 
5.1 INTRODUCTION 
 
The aim of the study was to investigate risk factors associated with tuberculosis co-
infection among HIV and Aids patients taking ART from Nekemte Hospital, Western 
Ethiopia.  
The objectives of the study were to: 
• Determine the socio demographic risk factors associated with TB co-infection in HIV 
and Aids patients taking antiretroviral therapy in Nekemte Hospital. 
 
• Identify behavioural and economic risk factors associated with TB co-infection in HIV 
and Aids patients taking antiretroviral therapy in Nekemte Hospital, Western 
Ethiopia. 
 
• Assess the knowledge on TB co-infection among HIV and Aids patients taking 
antiretroviral therapy in Nekemte Hospital, Western Ethiopia. 
 
5.2 THE MAIN FINDINGS OF THE STUDY 
 
 Educational status was one of the main socio-demographic variables that 
predisposes or protects HIV and Aids patients on ART from tuberculosis co-infection 
in Western Ethiopia. Patients who had formal education were protected from 
contracting tuberculosis co-infection than those without formal education. This 
implies that knowledge of the cause, mode of transmission, prevention and 
treatment of TB is key to the prevention of tuberculosis infection.  
 
 Findings from this study indicate that waste disposal, monthly income and history 
of contact with active tuberculosis patient or presence of persons with active 
tuberculosis in the house were major socio-economic conditions that were 
associated with the occurrence of active tuberculosis in HIV and Aids patients on 
ART in Western Ethiopia. Appropriate waste disposal outside the compound, having 
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a good monthly income and not being in contact with patients who have active 
tuberculosis were associated with protection from contracting active TB. 
 
 Respondents identified that knowledge of how to prevent tuberculosis, adherence 
to ART, and abstaining from any exposure to substance abuse has prevented them 
from developing active tuberculosis. This in turn means that those patients who do 
not adhere to ART treatment and do not know how to prevent tuberculosis, and 
were exposed to substance abuse had a high risk of contracting active tuberculosis. 
   
5.3 LIMITATIONS OF THE STUDY  
 
Possible limitations of the study: 
 A case control study can only identify associations 
 Recall bias might affect the accuracy of the information related to some of the risk  
factors; and even though the data were collected through use of a structured 
questionnaire, one cannot discount the existence of social desirability bias; 
therefore, it may limit the generalizability of the results. 
 Because the study was conducted in only one health facility in Ethiopia, it would 
be difficult to attempt to generalize the results of this research to the whole country. 
 The study did not include patients under the age of 18 since the Ethiopian law do 
not allow consent for children less than 18 years and cannot be generalized to these 
group of population.  
  
5.4 RECOMMENDATIONS 
  
Based on the study findings the following recommendations are made to address risk 
factors associated with tuberculosis co-infection in HIV and Aids patients and a variety of 
other factors that might be useful for further research.  
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5.4.1 Recommendations on improving health, social, and economic advantage  
  
• Patients with HIV and Aids should be provided with health education on 
opportunistic infections like tuberculosis in every health facility, and even in the 
community by health care professionals especially by trained health extension 
workers. 
• The quality of counselling should be considered when counselling patients who have 
just begun ART. Lack of ART adherence is noted as one of the risk factors 
predisposing patients to tuberculosis.  
• The government should focus on improving the educational status of the community 
as a whole and increasing their income as it would be greatly helpful in decreasing 
the emergence of active tuberculosis in HIV and Aids patients.  
5.4.2 Recommendations for further research 
  
• Replicating this study in other provinces of the country so as to ensure 
representativeness would allow generalizability of the findings.  
• Further study on the patients not included in this study group is helpful.  
• An investigation on medication adherence and development of active tuberculosis in 
HIV and Aids patients should be pursued. 
 
5.5 CONCLUSION 
  
This Chapter concluded the study by discussing its limitations and by making a variety of 
recommendations on the basis of the result obtained from the study. The results of this 
study imply there is a lot to do from health workers, researchers and policy makers 
concerning the TB/HIV co-infection. These can be used to address the risk factors in the 
development of active tuberculosis in HIV and Aids patients and can also be used for 
further study that addresses risk factors of active tuberculosis while taking ART treatment.  
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ANNEXURE A: Questionnaire 
QUESTIONNAIRE 
UNIVERSITY OF SOUTH AFRICA 
DEPARTMENT OF HEALTH STUDIES 
QUESTIONNAIRE FOR THE ASSESSMENT OF RISK FACTORS ASSOCIATED WITH 
TB CO-INFECTION IN HIV/AIDS PATIENTS ON ANTIRETROVIRAL THERAPY (ART) IN 
ONE OF PUBLIC HEALTH INSTITUTIONS IN NEKEMTE TOWN, WESTERN ETHIOPIA. 
The purpose of this study is to assess risk factors associated with TB co-infection in 
HIV/AIDS patients. Your participation in this study is important and is completely voluntary. 
The information requested from you will be used only for the study purpose. If you agree to 
complete the questionnaire, you will answer questions regarding yourself, your knowledge, 
and health seeking behaviour regarding different aspects of TB, HIV and TB/HIV co-
infection.  Your answers will be kept confidential and only the investigator and data 
collectors will have access to this information. Your name will not be written on the 
questionnaire or be kept in any other records. Your participation is voluntary and you may 
choose to stop the interview at any time. Completing the questionnaire will take about 30 
minutes.  
 
If you have anything unclear you can contact the researcher by:- 
                        Phone: - +251-91-105-3417 
                        E-mail: Obsa_2007@yahoo.com 
 
Thank you for your assistance.                                        Code________ 
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SECTION1. SOCIO DEMOGRAPHIC CHARACTERSTICS  
 
 
NO. QUESTIONNAIRE CATEGORY CODE 
101 Age Write in Numbers_______  
102 Sex 1 Male 
2. Female 
 
103 Religion 1.Orthodox  
2. Muslim 
3. Protestant 
4. Catholic 
5. Other(specify)________ 
 
104 Ethnicity 1.Oromo 
2.Amhara 
3.Tigre 
4.Guraghe 
5.Other(specify)________ 
 
105 Marital Status 1.Single 
2.Married 
3.Divorced 
4.Widowed 
5.Other(specify)________ 
 
106 Educational 
Status 
1.No education 
2.Religious Schooling  
2. Primary education(1-8) 
4.Secondary Education(9-12) 
5.Tertiary  Education(12+) 
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107 Occupational 
Status 
1.Unemployed 
2.Day laborer  
3. Housemaid 
4.Farmer 
5.Private employee 
6.Government employee 
7.NGO employee 
8.Other(Specify)_________ 
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Residence 1.Urban 
2.Rural 
 
 
SECTION 2 SOCIAL CONDITIONS 
NO. QUESTIONNAIRE CATEGORY CODE 
201 
 
 
Living room 
 
 
1.Number of 
rooms_______ 
2. Number of people in 
the household____ 
 
202 Walls of your house made of 
 
1.Mud/Mud bricks  
2.Cement 
3.Other(Please 
specify)_____ 
 
203  The floor of your house is made of 1.Mud 
2.Cement  
 
204 Do you have a separate kitchen? 1.Yes 
2.No 
 
205 Is there electricity in your house? 1.Yes 
2.No 
 
206 
 
Do animals (cattle’s and/or pets) live together 
with the people in the house in the same room? 
 
1.Yes 
2.No 
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207 Where do you dispose wastes from your 
house?  
1.Inside the compound 
2.Outside my compound 
 
208 What is your monthly income? 
 
1.<30USD 
2.≥30USD 
 
209 How many meals do you eat a day? 1.One to two times 
2.Three times 
3.Four to Five times 
 
210 
 
 
 
 
How long does it takes you to reach this health 
institution? 
 
 
 
1. Less than 30 minutes 
2. Less than an hour 
3. Half a day 
4. One day 
5. More than one day 
 
211 How much does it costs you to reach this health 
institution by car? 
1.Less than 17Birr(1USD) 
2. 17 to 34 Birr (1-2USD) 
3. >35 Birr(>2USD) 
 
212 Is there anyone living in your home infected with 
TB? 
1.Yes 
2.No 
 
213 If ‘Yes’ to 212 is he/she taking anti TB 
treatment? 
1.Yes 
2.No 
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SECTION 3: HEALTH SEEKING BEHAVIOUR, KNOWLEDGE, AND RISK 
BEHAVIOURS 
 
NO. QUESTIONNAIRE CATEGORY CODE 
301 
 
 
 
 
Where do you usually go for 
medical care when you are sick, 
or for treatment of a general 
health problem? 
1.Private clinic  
2.Government clinic or hospital 
3.Traditional healer 
4.Clinic run by a NGO or church 
5.Other (specify)______ 
 
302 When did you begin taking ART? 1.One year ago 
2. Within the past 2-5 years 
3.More than 5 years 
 
303 Do you take ART on a regular 
basis? 
1.Yes 
2.No 
 
304 If your answer is No for Q 303, 
why did you take irregularly/why 
did you interrupt? 
1.I caught a disease 
2.Distance to this health institution 
3.Side effects of the drugs 
4.Other (specify)________ 
 
305 In the past 5 years how often did 
you generally seek health care in 
a health institution EXCEPT 
when you go for ART? 
1. Once per year 
2. Twice a year or more 
3. Less than once a yr but at least 
    twice in the past 5 yrs 
4.Once in the past 5 years 
5. Never in the past 5 years 
6.Other (specify) _______ 
 
 
 
 
 
 
54 
 
306 Where did you first learn about 
TB? (Tick all that applies) 
1.Newspapers and magazines  
2.Radio 
3. TV. 
4.Billboards 
5.Brochures, posters etc 
6. Health workers 
7.Family, friends, and/or neighbors  
8.Religious leaders 
9.Teachers 
10.Other(specify) ________ 
 
 
307 How can a person get TB? 1.Eating together 
2.Cough from infected individual 
3.Infected raw milk 
4.Transplacental 
5.Other(specify)_________ 
 
308 How can a person prevent TB? 1.Only by drug(prophylaxis) 
2.Balanced diet 
3.Immunization 
4.Other(specify)__________ 
 
309 In your opinion, who can be 
infected with TB? (Tick all that 
applies) 
 
1.Anybody 
2.Poor people 
3.Homeless people 
4.Alcoholics 
5.Drug users 
6.People living with HIV/AIDS 
7.People who have been in prison 
8.Other (specify)___________ 
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310 Can TB be cured?     1.Yes 
2.No 
3.I don’t know 
 
311 Which of the following 
substances have you been 
exposed to? 
 
1. Smoking             
2.Drinking alcohol   
3.Chewing chat      
4.Not exposed at all 
5.Other (specify)_________ 
 
312 Do you know about opportunistic 
infections related to HIV/AIDS?            
1.Yes 
2.No 
 
313 Were you screened for Tb? 1.Yes 
2.No 
 
314 If your answer for Q 311 is Yes, 
What were the results? 
1.Positive 
2.Negative 
 
315 
 
Are you taking anti Tb drug 
currently?     
1.Yes 
2.No 
 
316 If your answer to Q 313 is Yes, 
when did you begin anti TB 
treatment? 
 
1.Since the past 3 months 
2.Since the past 2 months 
3.Since the past 1 month 
4.Since the past 2 weeks 
 
317 In your opinion, what type of 
change have you observed on 
your health after you started 
taking anti TB and ART? 
1.No change 
2.Improved 
3.Got severely ill 
 
318 Do you know of any HIV/AIDS 
patients who are co-infected with 
TB? 
 
 
1.Yes 
2.No 
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319 In your community, how is a 
person who has HIV infection 
usually regarded/treated? 
 
1.Most people reject him or her 
2.Most people are friendly, but they  
   generally try to avoid him or her 
3.The community mostly supports 
    and helps him or her 
4.Other (specify) ______ 
 
 
320 
 
Do you think that HIV positive 
people should be concerned 
about TB? 
 
1.Yes 
2.No 
 
 
321 What sources of information do 
you think can most effectively 
reach people like you with 
information on TB and HIV? 
1.Newspapers and magazines 
2.Radio 
3.TV  
4.Billboards 
5.Brochures, posters etc 
6.Health workers 
7.Family, friends, and neighbors 
8.Religious leaders 
9.Teachers 
10.Other(specify)_________ 
 
 
 
 
Thank you for your assistance. 
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ANNEXURE B: Afan Oromo translated questionnaire 
Unka Odeeffannoon Itti Sassaabamu 
Yuunvarsiitii Afrikaa Kibbaatti 
Muummee Qorannoo Fayyaa 
Unka Odeeffannoo mata duree ‘Hospitaala Naqamteetti namoota qoricha farra dhukkuba 
HIV/AIDS osoo fudhatanii wantoota dhukkuba maddeessaa TBf isaan saaxilan’ jedhu irratti 
qophaa’e.  
Kaayyoon qo’annoo kanaa sababoota (risk factors)  namoota qoricha farra dhukkuba 
HIV/AIDS osoo fudhatanii dhukkuba maddeessaa TBf saaxilan adda baasuudha. Qo’annaa 
kana keessatti hirmaachuun keessan guutummaatti fedhii keessan irratti kan hundaa’eefi 
odeeffannoon isinirraa argamus dhimma qo’annaaf qofa kan ooludha. Hirmaannaa 
keessaniin gaaffiiwwan haala jiraeenyaa, beekumsa waa’ee TB, HIV fi kanneen kana 
fakkaatan deebisuun itti hirmaattu. Deebii keessan hunda nama odeeffannoo kana 
sassaabu irraa kan hafe eenyuyyuu arguu hin danda’u. Maqaa keessan unka kana irratti 
galmeessuunis nu hin barbaachisu.Yeroo barbaachisaa ta’ettis deebii kennuu keessan 
addaan kutuun mirga keessani. Walumaagalatti, gaaffiiwwan kana xumuruuf daqiiqaa 30 
fudhata. 
 
Fedhii keessan yoo ta’e maaloo nuu mallatteessaa.  
______________________                         ____________________ 
Mallattoo       Guyyaa 
 
Wanta ifa isiniif hin taane hunda nama qo’annaa kana gaggeessu teessoo kanaan 
argachuu dandeessu.    Bilbila: - +251-91-105-3417 
                                     E-mail: Obsa_2007@yahoo.com  
                                                 47164093@mylife.unisa.ac.za  
 
 
            Galatoomaa.                                                                    Koodii__________ 
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KUTAA 1. ODEEFFANNOO DHUUNFAA FI HAWAASUMMAA 
Lakk. Odeeffannoo Garee Koodii 
101 Umurii Lakkoofsaan_____  
102 Saala 1.Dhiira 
2.Dhalaa 
 
103 Amantaa 1.Ortodoksii 
2.Musliima 
3.Pirotestaantii 
4.Kaatoolikii 
5.Gara biraa (kaa’i)______ 
 
104 Qomoo 1.Oromoo 
2.Amaara 
3.Tigiree 
4.Guraagee 
5.Gara biraa (kaa’i)______ 
 
105 Haala fuudhaa fi 
Heerumaa 
1.Kan hin fuune 
2.Kan fuudhe 
3.Kan hiike 
4.Kan irraa du’e/duute 
5.Gara biraa (kaa’i)______ 
 
106 Haala barumsaa 1.Hin baranne 
2.Mana barnoota amantaa 
3.Sadarkaa 1ffaa (1-8) 
4.Sadarkaa 2ffaa(9-12) 
5.Sadarkaa Olaanaa(12+) 
 
107 Haala hojii 1.Hojii kan hin qabne 
2.Dafqaan bulaa 
3.Hojjettuu manaa 
4.Qotee bulaa 
5.Hojii dhuunfaa 
6.Hojjetaa Mootummaa 
7.Hojjetaa Miti mootummaa(NGO) 
8.Gara biraa (kaa’i)_________ 
 
108 Bakka jireenyaa 1.Magaala 
2.Baadiyyaa 
 
KUTAA 2. HAALA HAWAASUMMAA 
Lakk. Odeeffannoo Garee Koodii 
201 Mana Jireenyaa 1.Baay’ina kutaa_______ 
2.Baay’ina nama mana keessa 
jiraatuu_____ 
 
202 Ijaarri/Gidgiddaan mana keessanii maal 
irraa hojjetame? 
1.Dhoqqee fi muka 
2.Simintoo/Bilookeetii 
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3.Gara biraa (kaa’i)______ 
 
203 Lafti mana keessanii 1.Biyyoo 
2.Simintoo/Liishoo 
 
204 Manni itti nyaata bilcheessan /Kushinaan 
qofaatti jiraa?  
1.Eeyyee 
2.Lakki 
 
205 Tajaajila Elektirikii/ibsaa qabduu? 1.Eeyyee 
2.Lakki 
 
206 Saawwanii fi bineensonni manaa(saree, 
adurree) nama waliin mana keessa 
jiraatuu? 
1.Eeyyee 
2.Lakki 
 
207 Kosii mana keessaa eessatti gattu? 1.Dallaa/axira manaa keessatti 
2.Dallaa manaan alatti 
 
208 Galiin isin ji’aan argattan meeqa? 1.<30USD 
2.≥30USD 
 
 
209 Guyyaatti nyaata/soorata al-meeqa 
nyaattu/soorattu? 
1.Tokkoo hanga Lamaa 
2.Al Sadii 
3.Afurii hanga Shanii 
 
210 Mana keessanii Hospitaala/Buufata 
Fayyaa kana ga’uuf sa’a meeqa isinitti 
fudhata? 
1.Daqiiqaa 30 gad 
2.Sa’a tokkoo gad 
3.Walakkaa guyyaa/Sa’a 6 
4.Guyyaa tokko 
5.Guyya tokkoo ol 
 
211 Konkolaataadhaan as gahuuf qarshii 
meeqa isin gaafata? 
1.Hanga Qarshii 17 (1USD) 
2.Qarshii 17-34 (1-2USD) 
3.Qarshii 35 fi ol (>2USD) 
 
212 Namni dhukkuba TB’n qabame mana 
keessan keessa jiraa? 
1.Eeyyee 
2.Lakki 
 
213 Deebiin Gaaffii Lakk.212 Eeyyee yoo ta’e, 
Namni kun dawaa farra dhukkuba TB 
fudhachaa jiraa? 
1.Eeyyee 
2.Lakki 
 
 
KUTAA 3. BEEKUMSA, BARSIIFATA YAALA FAYYAA FI AMALOOTA FAYYAA 
                NAMAA HUBAN 
Lakk Odeeffannoo Garee Koodii 
301 Yoo dhukkubsattan eessa 
deemuun yaalamtu? 
1.Kilinika dhuunfaa 
2.Hospitaala/kilinika Mootummaa 
3.Mana yaala Aadaa 
4.Kilinika NGO’n ykn Waldaa  amantaan 
gaggeeffamu. 
5.Gara biraa(kaa’i)__________ 
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302 
 
 
Qoricha farra HIV/AIDS 
fudhachuu yoom jalqabdan? 
1.Waggaa tokkoo as 
2.Waggaa 2-5 gidduu 
3.Waggaa 5 dura 
 
303 
 
 
Qoricha farra HIV/AIDS yeroo 
hunda osoo walirraa hin kutiin 
fudhattuu? 
1.Eeyyee 
2.Lakki 
 
 
304 Deebiin gaaffii 303 Lakki yoo ta’e, 
sababni addaan kutuu keessanii 
maali? 
1.Dhukkuba maddeessaan qabamuu 
2.Fageenya karaa 
3.Miidhaa qorichaarraa/side effects 
4.Gara biraa (kaa’i)___________ 
 
305 Qoricha farra HIV/AIDS 
barbaacha malee, waggoota 
shan(5) darban keessatti al 
meeqa mana yaalaa dhuftanii 
beektu? 
1.Waggaatti al tokko 
2.Waggaatti al lamaafi ol 
3.Waggoota shanan darban  
   Keessatti al lama 
4.Waggoota shaman darban 
   keessatti al tokko  
5.Tasuma dhufee hin beeku 
6.Gara biraa(kaa’i)_______ 
 
306 Waa’ee dhukkuba TB jalqaba 
eessaa dhageessan/bartan? 
(Deebiin lamaa fi isaa ol ni 
danda’ama) 
1.Gaazexaa 
2.Raadiyoo 
3.TV 
4.Beeksisa karaarraa/billboard 
5.Poosterii adda addaa 
6.Ogeessota Fayyaa 
7.Maatii, hiriyyaafi Ollaa irraa 
8.Abbootii Amantaa irraa 
9.Barsiisota irraa 
10.Gara biraa (kaa’i)______ 
 
307 Namni tokko TB dhaan akkamitti 
qabama? 
1.NamaTB qabu waliin yoo nyaate 
2.Qufaa nama TB qabamerraan 
3.Aannan seeraan hin danfinerraa 
4.Haadhaa gara mucaatti 
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5.Gara biraa(kaa’i)________ 
308 Dhukkuba TB akkamitti ofirraa 
dhowwuun danda’ama? 
1.Qorichaan qofa/prophylaxis 
2.Nyaata madaalamaa nyaachuun 
3.Talaallii fudhachuun 
4.Gara biraa (kaa’i)_________ 
 
309 Akka ilaalcha keessaniitti nama 
kamtu TBf saaxilamuu 
danda’a?(Deebiin lamaa ol ni 
danda’ama) 
1.Namni kamiyyuu ni saaxilama 
2.Nama hiyyeessa ta’e  
3.Nama mana jireenyaa hin qabne 
4.Nama dhugaatii dhugu 
5.Nama araada adda addaa qabu 
6.Dhukkubsattoota HIV/AIDS 
7.Nama mana sirreessaa ture 
8.Gara biraa (kaa’i)__________ 
 
310 Namni TBn qabame fayyuu ni 
danda’aa? 
1.Eeyyee 
2.Lakki 
 
311 Araada kamiif saaxilamtanii 
beektu? 
1.Sigaaraa xuuxuu 
2.Dhugaatii alkoolii 
3.Jimaa 
4.Gara biraa (kaa’i)__________ 
 
312 Waa’ee dhukkuboota 
maddeessaa HIV/AIDS waliin wal 
qabatanii beektuu? 
1.Eeyyee 
2.Lakki 
 
313 Dhukkuba TB qoratamtanii 
beektuu? 
1.Eeyyee 
2.Lakki 
 
314 Deebiin gaaffii 313 Eeyyee yoo 
ta’e, firiin qorannoo keessanii 
maali? 
1.TB qaba (positive) 
2.TB hin qabu (negative) 
 
315 Qoricha farra dhukkuba TB 
amma fudhachaa jirtuu? 
1.Eeyyee 
2.Lakki 
 
316 Deebiin Lakk.315 Eeyyee yoo 
ta’e, yoom fudhachuu eegaltan? 
1.Ji’a 3 kaasee 
2.Ji’a 2 kaasee 
3.Ji’a 1 kaasee 
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4.Torban 2 kaasee 
317 Akka ilaalcha keessaniitti, erga 
qoricha farra TB fi farra HIV/AIDS 
waliin fudhachuu jalqabdanii 
fayyummaa keessan irratti 
jijjiirama maalii argitani? 
1.Homayyuu hin agarre 
2.Fooyya’aa dhufeera 
3.Baayyee na dhukkubaa dhufe 
 
 
 
318 Dhukkubsataa HIV/AIDS kan 
dhukkuba maddeessaa TBn 
qabame beektuu? 
1.Eeyyee 
2.Lakki 
 
319 Uummata keessatti namni 
dhukkuba HIV/AIDSn qabame 
ilaalcha akkamii 
qaba/kennamaaf? 
1.Namni baay’een loogii irratti 
  geessisa 
2.Namni baay’een ofitti butu  
   garuu badaa hin amanan 
3.Uummanni isa gargaaru 
4.Gara biraa(kaa’i)_________ 
 
320 Dhukkubsattootni HIV/AIDS 
waa’een TB isaan ilaallata jettee 
yaaddaa? 
1.Eeyyee 
2.Lakki 
 
321 Namoonni akka kee waa’ee TB fi 
HIV/AIDS odeeffannoo gahaa 
karaa kam argachuu danda’u 
jettee yaadda? 
1.Gaazexaa 
2.Raadiyoo 
3.TV 
4.Beeksisa karaarraa/billboard 
5.Poosterii adda addaa 
6.Ogeessota Fayyaa 
7.Maatii, hiriyyaa fi Ollaa irraa 
8.Abbootii Amantaa irraa 
9.Barsiisota irraa 
10.Gara biraa (kaa’i)______ 
 
                                               Galatoomaa! 
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ANNEXURE C: UNISA Ethical clearance letter 
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ANNEXURE D: Nekemte city administration ethical clearance letter 
 
